ECR Minerals #ECR – Audited Financial Statements for Year Ended 30 September 2019

ECR Minerals plc is pleased to announce its audited financial statements for the year ended 30 September 2019. The information presented below has been extracted from the Company’s Annual Report and Accounts 2019. Copies of the Annual Report and Accounts 2019 will be posted to shareholders today and will be available on the Company’s website […]

Kibo Energy #KIBO – Corporate Update

Kibo Energy PLC, the multi-asset, Africa focused, energy company, announces a corporate update in response to the COVID-19 pandemic (‘the pandemic’).  Kibo places the safety and wellbeing of its employees and contractors as the highest priority. Accordingly, in response to the outbreak of the pandemic, which it has been monitoring closely, a business continuity programme […]

Race to stop the world getting sick: As coronavirus ravages the globe, experts work around the clock developing vaccines and trialling drugs in a desperate attempt to contain it

by Pat Hagan, Daily Mail As the needle slipped into Jennifer Haller’s arm, the world watched and held its breath. This was the moment last week when Jennifer became the first person to be injected with an experimental vaccine that scientists hope will help prevent future pandemics of the deadly Covid-19 coronavirus. Mother-of-two Jennifer, 43, […]

Wanted: People Willing to Get Sick to Find Coronavirus Vaccine

British lab is recruiting volunteers for study it says could speed development of Covid-19 vaccine By Denise Roland March 19, 2020 7:00 am ET Thousands of people have volunteered to be infected in the hope of finding a vaccine for the new coronavirus. hVIVO, a clinical research group in London, has attracted more than 20,000 […]

Tiziana Life Sciences developing TZLS-501 as a potential treatment for Coronavirus patients

Nasdaq and AIM listed Tiziana Life Sciences plc (Nasdaq: TSLA / AIM: TILS) has today announced that its TZLS-501 treatment could be a potential treatment for patients infected with coronavirus (COVID-19) who are at risk of respiratory failure. Tiziana, a biotechnology company focused on innovative therapeutics for inflammatory and autoimmune diseases, is expediting development of […]

Tiziana Life Sciences (Nasdaq: TLSA; AIM: TILS) – TZLS-501 Potential Treatment of Certain Patients Infected with Coronavirus COVID-19

New York/London, March 11,  2020 – Tiziana Life Sciences plc (Nasdaq: TLSA; AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for inflammatory and autoimmune diseases, announced today that it is expediting  development of  TZLS-501, a novel, fully human anti-interleukin-6 receptor (anti-IL6R) monoclonal antibody (mAb) for treatment of patients infected with coronavirus […]

Open Orphan #ORPH – Development of the World’s First Human Coronavirus Challenge Study Model

Open Orphan, the rapidly growing specialist Clinical Research Organisation (“CRO”) pharmaceutical services company whose London-based subsidiary hVIVO is the world leader in the provision of virology and vaccine challenge study services, is pleased to announce that it has commenced the development of the world’s first commercial human coronavirus challenge study model, also known as a Controlled […]

Irish Times – Open Orphan seals deal that could net more than €11.6m

by Colin Gleeson Dublin-listed pharma group announces contract with European biotech company Dublin-listed pharma services company Open Orphan has announced the signing of a new contract with a European biotech company that could yield it more than £10 million in revenue this year. Open Orphan, a European-focussed, rare and orphan drug consulting services platform, informed the Irish […]